Anti-phospholipid antibodies

This editorial refers to Low-dose aspirin versus low-dose aspirin plus low-intensity warfarin in thromboprophylaxis: a prospective, multicentre, randomized, open, controlled trial, in patients positive for antiphospholipid antibodies (ALIWAPAS), by Maria J. Cuadrado et al., doi:10.1093/rheumatology/ket313, on pages 275-84.